Adhera Therapeutics Inc (ATRX)
0.006
0.00 (0.00%)
USD |
OTCM |
May 01, 16:00
Adhera Therapeutics 1 Year Total Returns (Daily): -98.00% for May 1, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 01, 2024 | -98.00% |
April 30, 2024 | -97.03% |
April 29, 2024 | -97.03% |
April 26, 2024 | -97.31% |
April 25, 2024 | -97.74% |
April 24, 2024 | -98.75% |
April 23, 2024 | -98.88% |
April 22, 2024 | -99.00% |
April 19, 2024 | -99.00% |
April 18, 2024 | -99.00% |
April 17, 2024 | -98.83% |
April 16, 2024 | -98.68% |
April 15, 2024 | -98.67% |
April 12, 2024 | -98.17% |
April 11, 2024 | -98.36% |
April 10, 2024 | -98.28% |
April 09, 2024 | -98.28% |
April 08, 2024 | -98.28% |
April 05, 2024 | -97.94% |
April 04, 2024 | -97.94% |
April 03, 2024 | -97.94% |
April 02, 2024 | -97.65% |
April 01, 2024 | -97.65% |
March 28, 2024 | -97.60% |
March 27, 2024 | -97.51% |
Date | Value |
---|---|
March 26, 2024 | -97.82% |
March 25, 2024 | -97.47% |
March 22, 2024 | -97.73% |
March 21, 2024 | -97.45% |
March 20, 2024 | -97.90% |
March 19, 2024 | -97.38% |
March 18, 2024 | -97.98% |
March 15, 2024 | -98.09% |
March 14, 2024 | -98.22% |
March 13, 2024 | -97.92% |
March 12, 2024 | -98.00% |
March 11, 2024 | -98.07% |
March 08, 2024 | -98.00% |
March 07, 2024 | -97.71% |
March 06, 2024 | -97.82% |
March 05, 2024 | -97.88% |
March 04, 2024 | -98.03% |
March 01, 2024 | -97.85% |
February 29, 2024 | -97.42% |
February 28, 2024 | -97.42% |
February 27, 2024 | -98.38% |
February 26, 2024 | -98.38% |
February 23, 2024 | -97.92% |
February 22, 2024 | -97.92% |
February 21, 2024 | -97.92% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-99.27%
Minimum
Oct 24 2023
489.8%
Maximum
Oct 07 2021
-29.35%
Average
-61.94%
Median
Jul 24 2020
1 Year Total Returns (Daily) Benchmarks
AIM ImmunoTech Inc | -15.22% |
Perspective Therapeutics Inc | 176.8% |
Protalix BioTherapeutics Inc | -58.28% |
Electromed Inc | 69.55% |
Armata Pharmaceuticals Inc | 54.84% |